510(k) K100336
K100336 is an FDA 510(k) premarket notification submitted by Eragen Biosciences for the device "MULTICODE - RTX HERPES SIMPLEX VIRUS 1 AND 2 KIT, MODEL 3711". The FDA issued a decision of Substantially Equivalent on May 12, 2010. The device falls under product code OQO (Herpes Simplex Virus Nucleic Acid Amplification Assay), a Class II device regulated under 21 CFR 866.3305. Eragen Biosciences has 1 other 510(k) clearance on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 12, 2010
- Date Received
- Feb 5, 2010
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Herpes Simplex Virus Nucleic Acid Amplification Assay
- Device Class
- Class II
- Regulation Number
- 866.3305
- Review Panel
- MI
- Submission Type
- 510(k)
A polymerase chain reaction (pcr)-based qualitative in vitro diagnostic test for the detection and typing of herpes simplex virus (hsv) dna using vaginal swab specimens.
Need the full FDA record for Eragen Biosciences? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.